donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 09969 INNOCARE-B > Main Composition
09969 INNOCARE-B
11.460
-0.020-0.17%
All
YOY
Do not show
Business Unit:CNY

Loading...

Product

Loading...

Region Unit:CNY

Loading...

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

Company Overview More
Nuocheng Jianhua Pharmaceutical Co., Ltd. is an investment holding company mainly engaged in biomedical business. The company discovers, develops and commercializes potentially best-in-class and pioneered drugs for the treatment of cancer and autoimmune diseases. The company has established an integrated biomedical platform with internal research and development capabilities, including drug target identification and verification, preclinical evaluation, clinical trial design and execution, drug manufacturing and quality control, as well as commercial production and sales.
CEO: Jisong Cui
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...